Short answer · Medically reviewed summary · Last updated: 2026-05-08
CDKL5 deficiency disorder (CDD) is a rare, severe neurodevelopmental condition caused by mutations in the CDKL5 gene, which is essential for normal brain development and function. It is characterized by the early onset of intractable seizures, significant intellectual disability, and profound delays in motor and communication skills. What are the symptoms and body systems affected by CDKL5? The CDKL5 gene provides instructions for making a protein that helps regulate the activity of other nerve cells in the brain.
What is CDKL5
What is CDKL5? Plain-language, medically reviewed definition plus the lived reality told by patients.
CDKL5 deficiency disorder (CDD) is a rare, severe neurodevelopmental condition caused by mutations in the CDKL5 gene, which is essential for normal brain development and function. It is characterized by the early onset of intractable seizures, significant intellectual disability, and profound delays in motor and communication skills.
What are the symptoms and body systems affected by CDKL5?
The CDKL5 gene provides instructions for making a protein that helps regulate the activity of other nerve cells in the brain. Because this protein is critical for synaptic function, CDKL5 deficiency disorder primarily impacts the central nervous system. Individuals often experience a combination of the following clinical features:
- Early-onset epilepsy: Seizures typically begin within the first three months of life.
- Developmental delays: Significant challenges in sitting, walking, and speech acquisition.
- Visual impairment: Cortical visual impairment (CVI) is common, where the brain struggles to process visual information.
- Autonomic dysfunction: Issues with sleep patterns, temperature regulation, and gastrointestinal motility.
How common is CDKL5 and who is affected?
While the exact prevalence is difficult to determine, CDKL5 deficiency disorder is estimated to affect approximately 1 in 40,000 to 60,000 live births. It primarily affects females, though it can occur in males, often with more severe clinical presentations. Symptoms usually manifest in infancy, and because the CDKL5 gene is located on the X chromosome, the condition follows an X-linked inheritance pattern, though most cases arise from sporadic (de novo) mutations rather than being inherited from parents.
How is CDKL5 different from other conditions?
CDKL5 was historically misdiagnosed as an atypical variant of Rett syndrome. However, distinct clinical differences exist. Unlike classic Rett syndrome, which typically involves a period of normal development followed by regression, CDKL5 deficiency disorder is characterized by seizures starting almost immediately after birth and a lack of early developmental milestones. Within the DiseaseMaps community, 71 people with CDKL5 have shared their experiences, providing a vital network for families navigating this diagnosis.
Next steps
- Consult a pediatric neurologist or a geneticist to confirm a CDKL5 genetic diagnosis.
- Connect with the CDKL5 community at DiseaseMaps.org to share experiences with other families.
- Explore resources from the International CDKL5 Foundation for the latest clinical trial information.
- Engage in early intervention therapies, including physical, occupational, and speech therapy.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): CDKL5 deficiency disorder.
- Orphanet: CDKL5-related epilepsy.
- OMIM (Online Mendelian Inheritance in Man): CDKL5 deficiency disorder entry.
- International CDKL5 Foundation: Clinical resources and research updates.
